Back to Search
Start Over
83P Impact of treatment duration of extended adjuvant therapy with neratinib in early stage HER2+ HR+ breast cancer after trastuzumab-based therapy on patient outcomes.
- Source :
-
Annals of Oncology . 2020 Supplement 2, Vol. 31, pS43-S43. 1p. 1 Chart. - Publication Year :
- 2020
Details
- Language :
- English
- ISSN :
- 09237534
- Volume :
- 31
- Database :
- Academic Search Index
- Journal :
- Annals of Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 152683691
- Full Text :
- https://doi.org/10.1016/j.annonc.2020.03.023